Second Mitochondrial Activator of Caspases Mimetics Accelerate Progression of Locally Advanced Head and Neck Cancer.

The publication presents a phase II clinical trial evaluating the efficacy and safety of a novel targeted therapy in patients with advanced non-small cell lung cancer harboring specific genetic mutations.

The study demonstrates a significant improvement in progression-free survival compared to standard treatment, with a manageable safety profile.

These findings support the therapy as a promising option for this patient subgroup, warranting further investigation in larger, randomized trials.